CORONA Remedies acquires 7 brands from Bayer's pharma division in India

CORONA Remedies has bought seven brands from Bayer's pharmaceutical unit in India. The deal includes Noklot for heart patients. Women's health brands like Fostine and Ovidac are also part of the acquisition. This move allows CORONA Remedies to enter a new heart treatment area. It also strengthens their position in women's healthcare.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/0AdBOax
via IFTTT